Health
Firms begin study on chewable albendazole formulation
2 years agoDeputy Managing Director, Fidson Healthcare Plc., Mr. Biola Adebayo (left); Director, Clinical Research & Drug Development Liddie BE Ltd; Mr. Bolakale Ayinde; Chief Nurse, Liddie BE Ltd; Mrs. Osayuwa Oyebola Wuraola; Founder/Managing Director, Fidson Healthcare Plc, Dr. Fidelis Ayebae; Chief Operating Officer, Liddie BE Ltd, Mr. Wale Ogunsola; and Strategy and Marketing Director, Fidson Healthcare Plc. Mr. Olugbenga Olayeye, at the announcement of the Bio-Equivalent study for Albendazole in Lagos Nigeria.
Fidson Health Care Plc has partnered with a clinical research organisation, Liddie BE Ltd to conduct a Bioequivalence (BE) study on their chewable formulation of Albendazole tablets.